drugset / Trial / NCT05867550

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea

NCT05867550

Phase 4 Completed 162 enrolled Bahria University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to compare the efficacy of four different drugs in combination for management of irritable bowel syndrome (IBS)-associated diarrhea. The main question to answer is: * Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea? Participants will be divided into 3 treatment groups. * Each group will be given a combination of drugs for 2 weeks * At the end of study, efficacy of different drug combinations and their potential side effects will be compared between the treatment groups

Timeline

Start
2023-01-03
Primary completion
2023-03-27
Completion
2023-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 25 mg Oral
Comparator Mebeverine Small molecule 135 mg Oral
Comparator Psyllium husk Unknown 15 mg Oral
Comparator Psyllium husk Unknown 35 mg Oral
Comparator Rifaximin Other / unclassified 550 mg Oral